Catalent Pharma, UMN Pharma deal

By WIR Staff | Dec 17, 2012 | 8:00 AM GMT

Catalent granted UMN rights to use Catalent's GPEx gene product

Read the full 104 word article

How to gain access

Continue reading with a
two-week free trial.